An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Sellas Life Sciences Group
Pfizer
Butler Hospital
University of Kansas Medical Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fox Chase Cancer Center
INSYS Therapeutics Inc